HANTSON LUDWIG (CEO) reported 1 transaction at ALEXION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/23/2021ACC: 0000899866-21-000063
DirectorOfficer· CEO
Since Dec 2018
-637.57K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
637.57K disposed
Non-Derivative Transactions1
Common Stock, par value $.0001 per share
Direct
Shares
−580.81K
Price / share
—
Trade value
—
% of position
98.5%
7/21/2021
589.91K→9.10K
Total
Net shares
−580.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 7/21/2021 | D · Disposition | −580.81K | — | — | 98.5% | 589.91K | 9.10K |
| Total | −580.81K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock, par value $.0001 per share
56.76K shares
Shares
−56.76K
Strike price
118.83
Held after
0.00
Exercisable
—
7/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock, par value $.0001 per share56.76K shares | 7/21/2021 | D · Disposition | −56.76K | 118.83 | — | 0.00 |